LOC389641  promotes papillary thyroid cancer progression by regulating the EMT pathway.

In this study, we show that LOC389641 is involved in PTC, which suggests that it may be a target for TC therapies.
PMID: 32940082 [PubMed - in process]

Source: Future Medicine: Biomarkers in Medicine - September 19, 2020 Category: Internal Medicine Tags: Biomark Med Source Type: research